P

Inventor

ZHANG LIANSHAN

US38 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG LIANSHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JIANGSU HENGRUI MEDICINE CO

15 patents
US10905743B2Feb 2, 2021

Interleukin 15 protein complex

JIANGSU HENGRUI MEDICINE CO9 citations85
US11717559B2Aug 8, 2023

Interleukin 15 protein complex and use thereof

JIANGSU HENGRUI MEDICINE CO2 citations72
US10449250B2Oct 22, 2019

Anti-sclerostin antibody, antigen binding fragment and medical use thereof

JIANGSU HENGRUI MEDICINE CO2 citations69
US10899837B2Jan 26, 2021

B7-H3 antibody, antigen-binding fragment thereof and medical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations62
US11981733B2May 14, 2024

LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations60
US11525005B2Dec 13, 2022

Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof

JIANGSU HENGRUI MEDICINE CO1 citations60
US11155617B2Oct 26, 2021

LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations60
US12227583B2Feb 18, 2025

Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use

JIANGSU HENGRUI MEDICINE CO0 citations59
US11000518B2May 11, 2021

Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer

JIANGSU HENGRUI MEDICINE CO0 citations57
US12240904B2Mar 4, 2025

Use of anti-PD-1 antibody in combination with famitinib in preparation of drug for treating tumors

JIANGSU HENGRUI MEDICINE CO0 citations56
US11065239B2Jul 20, 2021

Use of EZH2 inhibitor combined with BTK inhibitor in preparing drug for treating tumor

JIANGSU HENGRUI MEDICINE CO0 citations51
US12162944B2Dec 10, 2024

Human IL-4R binding antibody, antigen binding fragment thereof, and medical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations49
US11471503B2Oct 18, 2022

Use of KOR agonist in combination with MOR agonist in preparing drug for treating pain

JIANGSU HENGRUI MEDICINE CO0 citations49
US10793643B2Oct 6, 2020

PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations49
US10857146B2Dec 8, 2020

Method for preventing or treating tumor diseases with a combination of tyrosine kinase inhibitor and CDK4/6 inhibitor

JIANGSU HENGRUI MEDICINE CO0 citations48

SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD

8 patents

LILLY CO ELI

5 patents

Shanghai hengrui pharmaceutical co ltd

5 patents

GLAESNER WOLFGANG

1 patent

LIU DONG

1 patent

HANSOH SHANGHAI HEALTHTECH CO LTD

1 patent

BEALS JOHN MICHAEL

1 patent

DIMARCHI RICHARD D

1 patent